1,636
Views
38
CrossRef citations to date
0
Altmetric
Review Article

Biogenic gold nanoparticles: As a potential candidate for brain tumor directed drug delivery

, &
Pages 311-317 | Received 28 Nov 2013, Accepted 14 Jan 2014, Published online: 03 Mar 2014
 

Abstract

Gold nanoparticles have tremendous application in the area of nanotechnology that raises new possibility in the treatment of brain tumor. These nanoparticles can be used for selectively gaining access to tumor due to their small size and modifiability. Gold nanoparticles are functionalized with various molecules such as anticancer drug, transferrin and monoclonal antibody to produce nanocarriers. These nanocarriers have ability to deliver the drug at targeted site. Transferrin crosses the blood-brain barrier because of the receptor-mediated endocytosis. The monoclonal antibody facilitates the release of anticancer drug at targeted sites. This approach of delivery saves the normal cells surrounding the tumor.

Acknowledgements

Authors are thankful to Dr R. P. Singh (Advisor) and Dr L. M. Bhardwaj (HOI), Amity Institute of Nanotechnology, Amity University, Noida, India for their encouragement and giving precious advice continuously for the above review article.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.